Why insider trading matters?
When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2022-09-22 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 19,875 | $84.17 | $1,672,839 | Yes |
| 2022-09-08 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 6,725 | $90.94 | $611,572 | Yes |
| 2022-08-15 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 19,875 | $104.74 | $2,081,772 | Yes |
| 2022-08-09 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 6,725 | $105.01 | $706,192 | Yes |
| 2022-08-09 | Wood Larry L | CVP, TAVR | Sell | 7,242 | $104.71 | $758,304 | Yes |
| 2022-08-05 | Zovighian Bernard J | CVP, TMTT | Sell | 4,811 | $103.66 | $498,708 | No |
| 2022-07-14 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 19,875 | $95.88 | $1,905,626 | Yes |
| 2022-07-08 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 6,725 | $97.60 | $656,360 | Yes |
| 2022-07-05 | Wood Larry L | CVP, TAVR | Sell | 7,242 | $95.90 | $694,486 | Yes |
| 2022-06-14 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 19,875 | $86.96 | $1,728,247 | Yes |
| 2022-06-14 | WANG HUIMIN | CVP, Japan & Intercontinental | Sell | 3,675 | $87.75 | $322,481 | Yes |
| 2022-06-13 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 6,725 | $90.02 | $605,410 | Yes |
| 2022-06-01 | Wood Larry L | CVP, TAVR | Sell | 7,242 | $100.53 | $728,053 | Yes |
| 2022-05-24 | Zovighian Bernard J | CVP, TMTT | Sell | 4,809 | $95.52 | $459,356 | No |
| 2022-05-10 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $94.82 | $3,086,494 | Yes |
| 2022-05-10 | Wood Larry L | CVP, TAVR | Sell | 7,242 | $96.13 | $696,181 | Yes |
| 2022-05-09 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Sell | 11,560 | $98.24 | $1,135,709 | Yes |
| 2022-05-04 | Szyman Catherine M. | CVP, Critical Care | Sell | 23,400 | $104.86 | $2,453,828 | Yes |
| 2022-04-29 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $107.80 | $3,508,849 | Yes |
| 2022-04-28 | Marsh Martha H. | Director | Sell | 28,722 | $108.09 | $3,104,564 | Yes |
| 2022-04-11 | Szyman Catherine M. | CVP, Critical Care | Sell | 20,000 | $122.04 | $2,440,814 | Yes |
| 2022-04-08 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Sell | 11,660 | $123.30 | $1,437,622 | Yes |
| 2022-04-08 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 11,050 | $123.34 | $1,362,906 | Yes |
| 2022-03-22 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $112.36 | $3,657,321 | Yes |
| 2022-03-14 | Szyman Catherine M. | CVP, Critical Care | Sell | 20,000 | $104.65 | $2,093,001 | Yes |
| 2022-03-11 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 11,050 | $106.00 | $1,171,355 | Yes |
| 2022-03-08 | WANG HUIMIN | CVP, Japan & Intercontinental | Sell | 3,675 | $107.60 | $395,430 | Yes |
| 2022-02-18 | Szyman Catherine M. | CVP, Critical Care | Sell | 20,000 | $106.31 | $2,126,253 | Yes |
| 2022-02-15 | MUSSALLEM MICHAEL A | Chairman & CEO | Sell | 32,550 | $110.09 | $3,583,289 | Yes |
| 2022-02-11 | BOBO DONALD E JR | CVP, Strategy/Corp Development | Sell | 11,050 | $111.49 | $1,231,924 | Yes |
Insider Smart
Insider Smart